Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CGEMCullinan Therapeutics, Inc.

Nasdaq · CIK 0001789972
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts223

Identity from submissions API

NameCullinan Therapeutics, Inc.
CIK0001789972
TickersCGEM
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN813879991
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-410-4650
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Cullinan Oncology, Inc. (2021-02-26T05:00:00.000Z → 2024-04-02T04:00:00.000Z)
  • Cullinan Management, Inc. (2020-12-01T05:00:00.000Z → 2021-02-22T05:00:00.000Z)
  • Cullinan Oncology, LLC (2020-11-02T05:00:00.000Z → 2021-01-06T05:00:00.000Z)
Business address
ONE MAIN STREET
SUITE 1350
CAMBRIDGE
MA
02142
MA
Mailing address
ONE MAIN STREET
SUITE 1350
CAMBRIDGE
MA
02142
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

471 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 10-Q 10-Q 0001193125-26-454417 001-39856 261537922 34 8862126 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-454408 001-39856 261537914 34 338928 1 1
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000639 005-91966 261537873 34 8375
2026-11-09 8-K 8-K 7.01,8.01,9.01 0001193125-26-452644 001-39856 261533805 34 218661 1 1
2026-11-06 4 4 0001193125-26-452004 8674
2026-11-05 144 xsl144X01/primary_doc.xml 0001950047-26-010744 001-39856 261527853 33 7151
2026-11-04 8-K 8-K 7.01,8.01,9.01 0001193125-26-446348 001-39856 261520347 34 251074 1 1
2026-10-02 8-K 8-K 7.01,8.01,9.01 0001193125-26-411011 001-39856 261433015 34 195051 1 1
2026-09-24 8-K 8-K 7.01,8.01,9.01 0001193125-26-400144 001-39856 261402148 34 193562 1 1
2026-09-14 8-K 8-K 7.01,8.01,9.01 0001193125-26-389844 001-39856 261375805 34 241974 1 1
2026-09-10 4 4 0001193125-26-387381 9181
2026-09-08 144 xsl144X01/primary_doc.xml 0001950047-26-009190 001-39856 261365390 33 7736
2026-08-14 4 4 0001193125-26-352523 9184
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002166 005-91966 261281309 34 25948
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000574 005-91966 261277455 34 7929
2026-08-13 144 xsl144X01/primary_doc.xml 0001950047-26-008087 001-39856 261274131 33 5841
2026-08-13 8-K 8-K 7.01,8.01,9.01 0001193125-26-347400 001-39856 261269397 34 218242 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000446 005-91966 261251751 34 8404
2026-08-06 10-Q 10-Q 0001193125-26-336717 001-39856 261245948 34 8220325 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336700 001-39856 261245921 34 334703 1 1
2026-07-07 4 4 0001193125-26-297605 9181
2026-07-06 144 xsl144X01/primary_doc.xml 0001950047-26-006865 001-39856 261156247 33 6422
2026-07-02 4 4 0001193125-26-294869 5491
2026-07-02 4 4 0001193125-26-294863 5505
2026-06-18 4 4 0001193125-26-276060 5830
2026-06-18 4 4 0001193125-26-276059 5820
2026-06-18 4 4 0001193125-26-276057 5830
2026-06-18 4 4 0001193125-26-276056 5792
2026-06-18 4 4 0001193125-26-276055 5820
2026-06-18 4 4 0001193125-26-276054 5841
2026-06-16 8-K 8-K 5.07 0001193125-26-272890 001-39856 261095784 34 171865 1 1
2026-06-10 8-K 8-K 7.01,8.01,9.01 0001193125-26-264916 001-39856 261078051 34 271693 1 1
2026-06-08 8-K 8-K 7.01,8.01,9.01 0001193125-26-260640 001-39856 261070968 34 311500 1 1
2026-05-18 8-K 8-K 7.01,8.01,9.01 0001193125-26-229173 001-39856 26995081 34 220988 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001387 005-91966 26987057 34 25822
2026-05-07 10-Q 10-Q 0001193125-26-210304 001-39856 26950822 34 7260729 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210290 001-39856 26950789 34 290590 1 1
2026-05-06 4 4 0001193125-26-209307 11091
2026-05-05 144 xsl144X01/primary_doc.xml 0001950047-26-004070 001-39856 26943926 33 10861
2026-04-28 S-3ASR S-3ASR 0001193125-26-183596 333-295363 26903182 33 1494031 1 1
2026-04-28 DEFA14A DEFA14A 0001193125-26-183472 001-39856 26903056 34 313784
2026-04-28 DEF 14A DEF 14A 0001193125-26-183465 001-39856 26903049 34 5345930 1 1
2026-04-28 ARS ARS 0001193125-26-183459 001-39856 26903044 34 2257525
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001005 005-91966 26799675 34 7484
2026-03-10 S-8 S-8 0001193125-26-099373 333-294168 26737241 33 327213 1 1
2026-03-10 10-K 10-K 0001193125-26-099362 001-39856 26737221 34 13720244 1 1
2026-03-10 8-K 8-K 2.02,9.01 0001193125-26-099355 001-39856 26737213 34 355720 1 1
2026-03-09 4 4 0001193125-26-098781 9043
2026-03-05 144 xsl144X01/primary_doc.xml 0001950047-26-002270 001-39856 26726639 33 13711
2026-03-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001907884-26-000005 005-91966 26720734 34 9629
2026-02-26 4 4 0001193125-26-077259 5463
2026-02-25 4 4 0001193125-26-072002 7002
2026-02-25 4 4 0001193125-26-072001 4934
2026-02-25 4 4 0001193125-26-072000 4952
2026-02-25 4 4 0001193125-26-071997 4930
2026-02-25 144 xsl144X01/primary_doc.xml 0001950047-26-001779 001-39856 26679361 33 10828
2026-02-23 4 4 0001193125-26-064257 4952
2026-02-23 4 4 0001193125-26-064256 10078
2026-02-23 4 4 0001193125-26-064255 4930
2026-02-23 4 4 0001193125-26-064254 4934
2026-02-23 4 4 0001193125-26-064261 4944
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001659 001-39856 26665755 33 10830
2026-02-20 144 xsl144X01/primary_doc.xml 0001950047-26-001588 001-39856 26660344 33 10112
2026-02-19 4 4 0001193125-26-059641 5624
2026-02-19 4 4 0001193125-26-059640 5646
2026-02-19 4 4 0001193125-26-059639 5627
2026-02-19 4 4 0001193125-26-059638 5640
2026-02-19 4 4 0001193125-26-059637 7223
2026-02-19 4 4 0001193125-26-059636 7238
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000457 005-91966 26641207 34 25864
2026-02-13 4 4 0001193125-26-051700 4958
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000065 005-91966 26581878 34 7282
2026-01-23 4 4 0001193125-26-021225 4957
2026-01-22 144 xsl144X01/primary_doc.xml 0001950047-26-000636 001-39856 26552156 33 8065
2026-01-08 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-006998 001-39856 26517355 34 225282 1 1
2026-01-05 4 4 0001193125-26-002687 5700
2025-12-29 4 4 0001193125-25-335482 4934
2025-12-22 4 4 0001193125-25-328909 5463
2025-12-19 4 4 0001193125-25-327033 5268
2025-12-19 4 4 0001193125-25-327030 4952
2025-12-19 4 4 0001193125-25-327027 4959
2025-12-19 144 xsl144X01/primary_doc.xml 0001950047-25-010561 001-39856 251587862 33 7214
2025-12-16 4 4 0001193125-25-321122 6834
2025-12-15 144 xsl144X01/primary_doc.xml 0001950047-25-010308 001-39856 251571803 33 5809
2025-12-08 8-K 8-K 7.01,8.01,9.01 0001193125-25-310764 001-39856 251554994 34 245389 1 1
2025-11-25 4 4 0001193125-25-297549 4958
2025-11-24 144 xsl144X01/primary_doc.xml 0001950047-25-009279 001-39856 251513432 33 5317
2025-11-21 8-K 8-K 1.02 0001193125-25-291448 001-39856 251508428 34 145632 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112463 005-91966 251485684 34 18678
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004966 005-91966 251484287 34 11200
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-001585 005-91966 251479016 34 16900
2025-11-06 10-Q 10-Q 0001193125-25-268066 001-39856 251456126 34 9176033 1 1
2025-11-06 8-K 8-K 2.02,8.01,9.01 0001193125-25-268041 001-39856 251456077 34 353299 1 1
2025-11-03 8-K 8-K 7.01,8.01,9.01 0001193125-25-261799 001-39856 251442347 34 237531 1 1
2025-10-30 4 xslF345X05/ownership.xml 0000902664-25-004662 8203
2025-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000125 005-91966 251434633 34 6589
2025-10-21 4 xslF345X05/ownership.xml 0000902664-25-004499 14656
2025-10-10 4 xslF345X05/ownership.xml 0000902664-25-004379 12521
2025-10-10 3 xslF345X02/ownership.xml 0000902664-25-004378 6726
2025-10-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004377 005-91966 251388959 34 10870
2025-09-04 8-K 8-K 7.01,8.01,9.01 0000950170-25-112949 001-39856 251291815 34 28332229 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003576 005-91966 251214204 34 14768
2025-08-08 4 4 0000950170-25-106028 5750
2025-08-08 4 4 0000950170-25-106029 5701
2025-08-08 3 3 0000950170-25-106027 17939
2025-08-08 3 3 0000950170-25-106026 18377
2025-08-07 10-Q 10-Q 0000950170-25-104551 001-39856 251191547 34 9948031 1 1
2025-08-07 8-K 8-K 2.02,5.02,9.01 0000950170-25-104547 001-39856 251191523 34 398219 1 1
2025-08-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-074813 005-91966 251191090 34 27801
2025-06-16 4 4 0000950170-25-086737 5650
2025-06-16 4 4 0000950170-25-086732 5660
2025-06-16 4 4 0000950170-25-086726 5660
2025-06-16 4 4 0000950170-25-086721 5650
2025-06-16 4 4 0000950170-25-086718 5629
2025-06-12 8-K 8-K 5.07 0000950170-25-085425 001-39856 251043054 34 181720 1 1
2025-06-04 8-K 8-K 1.01,7.01,9.01 0000950170-25-081601 001-39856 251023085 34 10532551 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066384 001-39856 25923863 34 7513807 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066382 001-39856 25923855 34 316030 1 1
2025-04-25 ARS ARS 0000950170-25-058320 001-39856 25869917 34 2000321
2025-04-25 DEFA14A DEFA14A 0000950170-25-058318 001-39856 25869909 34 397771
2025-04-25 DEF 14A DEF 14A 0000950170-25-058316 001-39856 25869902 34 3994261 1 1
2025-02-27 4 4 0000950170-25-029201 4900
2025-02-27 4 4 0000950170-25-029199 4894
2025-02-27 4 4 0000950170-25-029200 4935
2025-02-27 4 4 0000950170-25-029197 4913
2025-02-27 S-8 S-8 0000950170-25-028351 333-285302 25672974 33 327524 1 1
2025-02-27 10-K 10-K 0000950170-25-028346 001-39856 25672958 34 13202466 1 1
2025-02-27 8-K 8-K 2.02,9.01 0000950170-25-028343 001-39856 25672939 34 369431 1 1
2025-02-21 4 4 0000950170-25-025032 7210
2025-02-21 4 4 0000950170-25-025031 7192
2025-02-21 4 4 0000950170-25-025030 7188
2025-02-21 4 4 0000950170-25-025029 7169
2025-02-21 4 4 0000950170-25-025028 7175
2025-02-21 4 4 0000950170-25-025027 7188
2025-01-29 8-K 8-K 7.01,8.01,9.01 0000950170-25-010199 001-39856 25566642 34 273697 1 1
2025-01-07 4 4 0000950170-25-002946 5435
2025-01-06 144 xsl144X01/primary_doc.xml 0001950047-25-000127 001-39856 25511460 33 8148
2024-12-27 4 4 0000950170-24-140856 4873
2024-12-20 4 4 0000950170-24-139125 4936
2024-12-20 4 4 0000950170-24-139124 4902
2024-12-20 4 4 0000950170-24-139123 4914
2024-12-16 4 4 0000950170-24-136726 4933
2024-11-14 SC 13G/A SC 13G/A 0001140361-24-046977 005-91966 241464100 34 59091
2024-11-14 SC 13G/A AMENDMENT NO. 5 TO SCHEDULE 13G 0000921895-24-002715 005-91966 241462882 34 280719
2024-11-12 SC 13G/A UnitedStates_13G__CullinanTh.txt 0000932471-24-000938 005-91966 241446933 34 6853
2024-11-08 SC 13G us2300311063_110824.txt 0002012383-24-003532 005-91966 241439645 34 14184
2024-11-07 4 4 0000950170-24-123538 5438
2024-11-07 10-Q 10-Q 0000950170-24-122795 001-39856 241433162 34 6552227 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122778 001-39856 241433108 34 344905 1 1
2024-11-04 SC 13G/A UnitedStates_13G__CullinanTh.txt 0000932471-24-000300 005-91966 241421443 34 5902
2024-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-24-000155 005-91966 241414129 34 24841
2024-10-22 SC 13G us2300311063_102224.txt 0002012383-24-001259 005-91966 241386145 34 14172
2024-10-16 8-K 8-K 7.01,8.01,9.01 0000950170-24-114841 001-39856 241373280 34 32274820 1 1
2024-09-17 8-K 8-K 7.01,8.01,9.01 0000950170-24-107011 001-39856 241302581 34 192255 1 1
2024-09-09 4 4 0000950170-24-104820 5438
2024-09-05 144 xsl144X01/primary_doc.xml 0001950047-24-006826 001-39856 241281728 33 6009
2024-08-09 3 3 0000950170-24-094919 16431
2024-08-09 4 4 0000950170-24-094861 5684
2024-08-08 10-Q 10-Q 0000950170-24-093320 001-39856 241186041 34 6166412 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093314 001-39856 241186023 34 339706 1 1
2024-07-09 4 4 0000950170-24-082485 5438
2024-07-05 144 xsl144X01/primary_doc.xml 0001950047-24-005251 001-39856 241102795 33 6771
2024-07-02 4 4 0000950170-24-080961 5360
2024-06-27 4 4 0000950170-24-078678 5666
2024-06-27 4 4 0000950170-24-078677 5668
2024-06-27 4 4 0000950170-24-078676 5641
2024-06-27 4 4 0000950170-24-078675 5662
2024-06-27 8-K 8-K 5.07 0000950170-24-078554 001-39856 241080096 34 163397 1 1
2024-06-11 4 4 0000950170-24-072095 6712
2024-06-07 SC 13G/A us2300311063_060724.txt 0001086364-24-007801 005-91966 241028569 34 12998
2024-06-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-06-04 16:00:00 9999999995-24-001737 333-279452 241020607 33 2054
2024-06-04 424B3 424B3 0001193125-24-154362 333-279452 241019213 33 231283
2024-06-03 8-K 8-K 7.01,8.01,9.01 0000950170-24-067662 001-39856 241012055 34 20985645 1 1
2024-05-31 CORRESP filename1.htm 0001193125-24-151734 6701
2024-05-23 8-K 8-K 7.01,8.01,9.01 0000950170-24-064025 001-39856 24979532 34 258172 1 1
2024-05-23 4 4 0000950170-24-063948 10275
2024-05-20 UPLOAD filename1.pdf 0000000000-24-005835 333-279452 40581
2024-05-16 4 4 0000950170-24-061228 5673
2024-05-16 3 3 0000950170-24-061219 15470
2024-05-16 S-3 S-3 0001193125-24-140544 333-279452 24955647 33 1179649
2024-05-16 ARS ARS 0000950170-24-060796 001-39856 24953563 34 5701473
2024-05-16 DEFA14A DEFA14A 0001193125-24-139980 001-39856 24953528 34 956621
2024-05-16 DEF 14A DEF 14A 0001193125-24-139976 001-39856 24953525 34 1045917
2024-05-15 10-Q 10-Q 0000950170-24-060535 001-39856 24951748 34 5780988 1 1
2024-05-15 8-K 8-K 2.02,5.02,9.01 0000950170-24-060481 001-39856 24950910 34 310951 1 1
2024-05-08 4 4 0000950170-24-056093 16312
2024-05-06 144 xsl144X01/primary_doc.xml 0001950047-24-003409 001-39856 24918044 33 6057
2024-04-30 4 4 0000950170-24-050844 5792
2024-04-30 3 3 0000950170-24-050840 15612
2024-04-29 8-K 8-K 5.02,9.01 0000950170-24-049436 001-39856 24886559 34 317806 1 1
2024-04-24 SC 13G e663545_sc13g-ct.htm 0001193805-24-000557 005-91966 24872139 34 103526
2024-04-16 8-K 8-K 1.01,3.02,5.03,7.01,8.01,9.01 0000950170-24-044593 001-39856 24846101 34 22983345 1 1
2024-04-02 3 3 0000950170-24-040615 24587
2024-03-14 S-8 S-8 0000950170-24-031144 333-277914 24747922 33 143596
2024-03-14 10-K 10-K 0000950170-24-031143 001-39856 24747917 34 16177615 1 1
2024-03-14 8-K 8-K 2.02,9.01 0000950170-24-031140 001-39856 24747911 34 439166 1 1
2024-02-23 4 4 0000950170-24-019463 7087
2024-02-23 4 4 0000950170-24-019462 7064
2024-02-23 4 4 0000950170-24-019458 7099
2024-02-23 4 4 0000950170-24-019455 7070
2024-02-23 4 4 0000950170-24-019456 7105
2024-02-23 4 4 0000950170-24-019457 7082
2024-02-14 SC 13G SC 13G 0001140361-24-008097 005-91966 24641736 34 48796
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023975 005-91966 24640076 34 338203
2024-02-14 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0000921895-24-000457 005-91966 24633594 34 280704
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020716 005-91966 24627878 34 13235
2024-02-06 SC 13G cull23in.htm 0000038777-24-000011 005-91966 24598582 34 186152
2024-02-02 4 4 0000950170-24-010975 8970
2024-02-01 144 xsl144X01/primary_doc.xml 0001950047-24-000577 001-39856 24587567 33 7121
2024-01-30 4 4 0000950170-24-009047 11194
2024-01-29 SC 13G us2300311063_012924.txt 0001086364-24-005553 005-91966 24574899 34 13736
2024-01-29 144 xsl144X01/primary_doc.xml 0001950047-24-000496 001-39856 24574063 33 6402
2024-01-24 4 4 0000950170-24-007032 16168
2024-01-22 144 xsl144X01/primary_doc.xml 0001950047-24-000401 001-39856 24549070 33 5710
2024-01-08 8-K/A 8-K/A 2.02 0000950170-24-002936 001-39856 24520289 34 163295 1 1
2024-01-08 8-K 8-K 2.01 0000950170-24-002745 001-39856 24518623 34 160972 1 1
2023-12-27 4 4 0000950170-23-073405 4782
2023-12-22 4 4 0000950170-23-072756 4788
2023-12-22 4 4 0000950170-23-072755 5305
2023-12-22 4 4 0000950170-23-072754 4817
2023-12-22 4 4 0000950170-23-072753 4823
2023-12-20 4 4 0000950170-23-071987 4787
2023-12-20 4 4 0000950170-23-071988 4822
2023-12-20 4 4 0000950170-23-071986 4800
2023-12-20 4 4 0000950170-23-071985 4816
2023-12-13 4 4 0000950170-23-070143 4735
2023-12-13 4 4 0000950170-23-070142 4741
2023-11-08 10-Q 10-Q 0000950170-23-060679 001-39856 231385953 34 8338260 1 1
2023-11-08 8-K 8-K 2.02,9.01 0000950170-23-060673 001-39856 231385939 34 512067 1 1
2023-09-07 SC 13G/A us2300311063_090623.txt 0001306550-23-009882 005-91966 231241196 34 12768
2023-08-10 10-Q 10-Q 0000950170-23-040964 001-39856 231157220 34 8858099 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-040950 001-39856 231157151 34 518856 1 1
2023-07-05 4 4 0000950170-23-031858 5155
2023-06-29 4 4 0000950170-23-030805 4700
2023-06-21 4 4 0000950170-23-029161 4569
2023-06-21 4 4 0000950170-23-029160 4742
2023-06-21 4 4 0000950170-23-029158 4598
2023-06-21 4 4 0000950170-23-029157 4582
2023-06-14 4 4 0000950170-23-027985 4735
2023-06-14 4 4 0000950170-23-027984 4742
2023-06-14 8-K 8-K 5.02,5.07 0000950170-23-027958 001-39856 231014298 34 186484 1 1
2023-06-12 4 4 0000950170-23-027540 5467
2023-06-12 4 4 0000950170-23-027539 5338
2023-06-12 4 4 0000950170-23-027538 5336
2023-06-12 4 4 0000950170-23-027537 5311
2023-06-08 4 4 0000950170-23-027063 13724
2023-06-06 144 xsl144X01/primary_doc.xml 0001950047-23-001322 001-39856 23996160 33 4918
2023-05-25 8-K 8-K 7.01,8.01,9.01 0001193125-23-154347 001-39856 23961891 34 218202 1 1
2023-05-24 4 4 0000950170-23-023939 4698
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013364 4968
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013361 4932
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013360 4945
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013358 4961
2023-05-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-18 16:00:00 9999999995-23-001468 333-270384 23937831 33 1896
2023-05-16 4 4 0000950170-23-022557 4740
2023-05-16 4 4 0000950170-23-022548 4791
2023-05-16 CORRESP filename1.htm 0001193125-23-146070 7796
2023-05-11 S-3/A S-3/A 0001193125-23-142126 333-270384 23911885 33 756288
2023-05-11 10-Q 10-Q 0000950170-23-021253 001-39856 23911190 34 8536278 1 1
2023-05-11 8-K 8-K 2.02,9.01 0001193125-23-142014 001-39856 23911034 34 232747 1 1
2023-04-26 4 4 0000950170-23-014838 4699
2023-04-21 DEFA14A DEFA14A 0001193125-23-109215 001-39856 23834498 34 889365
2023-04-21 DEF 14A DEF 14A 0001193125-23-109206 001-39856 23834491 34 966776
2023-04-20 4 4 0000950170-23-013705 4705
2023-04-20 4 4 0000950170-23-013702 4734
2023-04-20 4 4 0000950170-23-013701 4741
2023-04-20 4 4 0000950170-23-013697 4718
2023-04-14 4 FORM 4 SUBMISSION 0000899243-23-011298 4962
2023-04-14 4 FORM 4 SUBMISSION 0000899243-23-011292 4969
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009718 4962
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009717 4933
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009716 4969
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009715 4946
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009714 4960
2023-03-17 CORRESP filename1.htm 0001193125-23-073850 6374
2023-03-09 CORRESP filename1.htm 0001193125-23-066254 6921
2023-03-09 UPLOAD filename1.pdf 0000000000-23-002325 40387
2023-03-09 S-8 S-8 0001193125-23-065392 333-270389 23718304 33 67691
2023-03-09 S-8 S-8 0001193125-23-065384 333-270387 23718290 33 156131
2023-03-09 S-3 S-3 0001193125-23-065343 333-270384 23718243 33 1152253
2023-03-09 10-K 10-K 0000950170-23-006839 001-39856 23718170 34 19889559 1 1
2023-03-09 8-K 8-K 2.02,9.01 0001193125-23-065289 001-39856 23718155 34 239633 1 1
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006004 12316
2023-02-21 4 FORM 4 SUBMISSION 0000899243-23-005736 12241
2023-02-21 4 FORM 4 SUBMISSION 0000899243-23-005735 12230
2023-02-21 4 FORM 4 SUBMISSION 0000899243-23-005732 7461
2023-02-21 4 FORM 4 SUBMISSION 0000899243-23-005731 13210
2023-02-21 4 FORM 4 SUBMISSION 0000899243-23-005729 7485
2023-02-21 4 FORM 4 SUBMISSION 0000899243-23-005728 12225
2023-02-15 SC 13G/A SC 13G/A 0001104659-23-022282 005-91966 23634463 34 317815
2023-02-14 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-23-000530 005-91966 23625059 34 278163
2023-02-14 8-K 8-K 1.01,2.02,7.01,9.01 0001193125-23-036285 001-39856 23620989 34 207419 1 1
2023-02-13 SC 13G/A CHI ADVISORS LLC 0001085146-23-001068 005-91966 23616224 34 28017
2023-02-10 5 FORM 5 SUBMISSION 0001209191-23-008382 10753
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015741 005-91966 23602909 34 13153
2023-02-03 SC 13G us2300311063_020323.txt 0001306550-23-007046 005-91966 23584700 34 13456
2023-01-19 4 OWNERSHIP DOCUMENT 0000921895-23-000144 34553
2023-01-19 8-K 8-K 3.02,5.03,9.01 0001193125-23-011002 001-39856 23537867 34 428090 1 1
2023-01-06 4 FORM 4 SUBMISSION 0000899243-23-001157 5335
2022-11-29 4 FORM 4 SUBMISSION 0000899243-22-037126 14269
2022-11-14 10-Q 10-Q 0000950170-22-024683 001-39856 221380196 34 9842713 1 1
2022-11-14 8-K 8-K 2.02,9.01 0001193125-22-283667 001-39856 221380182 34 239221 1 1
2022-11-02 4 FORM 4 SUBMISSION 0000899243-22-034765 5708
2022-11-02 3 FORM 3 SUBMISSION 0000899243-22-034763 7698
2022-11-02 8-K 8-K 5.02,9.01 0001193125-22-275466 001-39856 221352376 34 159022 1 1
2022-10-25 8-K 8-K 1.01,7.01,9.01 0001193125-22-267965 001-39856 221327182 34 185708 1 1
2022-09-29 4 FORM 4 SUBMISSION 0000899243-22-032236 9475
2022-08-16 4 FORM 4 SUBMISSION 0000899243-22-028821 5800
2022-08-16 3 FORM 3 SUBMISSION 0000899243-22-028820 3151
2022-08-10 10-Q 10-Q 0000950170-22-016258 001-39856 221150396 34 11581376 1 1
2022-08-10 8-K 8-K 2.02,9.01 0001193125-22-216798 001-39856 221150395 34 243454 1 1
2022-08-09 4 FORM 4 SUBMISSION 0000899243-22-028132 9453
2022-08-04 4 OWNERSHIP DOCUMENT 0001104659-22-086343 22637
2022-07-26 4 FORM 4 SUBMISSION 0000899243-22-026737 9453
2022-07-21 4 FORM 4 SUBMISSION 0000899243-22-026470 7498
2022-07-12 4 FORM 4 SUBMISSION 0000899243-22-025971 7497
2022-07-05 4 FORM 4 SUBMISSION 0000899243-22-025082 5355
2022-07-05 4 FORM 4 SUBMISSION 0000899243-22-025080 5330
2022-07-05 4 FORM 4 SUBMISSION 0000899243-22-025077 5312
2022-06-28 4 OWNERSHIP DOCUMENT 0001104659-22-075392 23711
2022-06-27 8-K 8-K 1.01,2.01,7.01,9.01 0001193125-22-182838 001-39856 221044717 34 311253 1 1
2022-06-24 8-K 8-K 5.07 0001193125-22-181528 001-39856 221040369 34 160060 1 1
2022-06-23 4 OWNERSHIP DOCUMENT 0001104659-22-073980 22699
2022-06-23 4 FORM 4 SUBMISSION 0000899243-22-023773 5662
2022-06-23 4 FORM 4 SUBMISSION 0000899243-22-023771 5664
2022-06-23 4 FORM 4 SUBMISSION 0000899243-22-023769 5666
2022-06-23 4 FORM 4 SUBMISSION 0000899243-22-023767 5668
2022-06-07 4 FORM 4 SUBMISSION 0000899243-22-021346 5235
2022-06-03 4 OWNERSHIP DOCUMENT 0000921895-22-001898 26284
2022-05-16 4 OWNERSHIP DOCUMENT 0001104659-22-061591 24645
2022-05-16 4 OWNERSHIP DOCUMENT 0000921895-22-001689 29407
2022-05-16 10-Q 10-Q 0000950170-22-009937 001-39856 22925406 34 10032492 1 1
2022-05-16 8-K 8-K 2.02,9.01 0001193125-22-150830 001-39856 22925354 34 230056 1 1
2022-05-12 8-K 8-K 1.01,2.02,7.01,9.01 0001193125-22-147984 001-39856 22915560 34 5166808 1 1
2022-04-29 DEFA14A DEFA14A 0001193125-22-130049 001-39856 22870072 34 383721
2022-04-29 DEF 14A DEF 14A 0001193125-22-130030 001-39856 22870050 34 930960
2022-04-05 4 OWNERSHIP DOCUMENT 0000921895-22-001132 25368
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012380 5657
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012378 5663
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012376 5661
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012375 5659
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012373 5665
2022-03-17 10-K 10-K 0000950170-22-004002 001-39856 22746737 34 20802836 1 1
2022-03-17 8-K 8-K 2.02,9.01 0001193125-22-077804 001-39856 22746719 34 242732 1 1
2022-03-10 S-8 S-8 0001193125-22-072010 333-263428 22729526 33 67454
2022-03-07 4 FORM 4 SUBMISSION 0000899243-22-009841 5611
2022-03-03 8-K 8-K 5.02,9.01 0001193125-22-063699 001-39856 22706813 34 259775 1 1
2022-03-02 4 FORM 4 SUBMISSION 0000899243-22-008730 5787
2022-03-02 4 FORM 4 SUBMISSION 0000899243-22-008729 5684
2022-03-02 3 FORM 3 SUBMISSION 0000899243-22-008727 7829
2022-03-02 3 FORM 3 SUBMISSION 0000899243-22-008726 7802
2022-02-15 4 FORM 4 SUBMISSION 0000899243-22-006427 7483
2022-02-15 4 FORM 4 SUBMISSION 0000899243-22-006421 7466
2022-02-15 4 FORM 4 SUBMISSION 0000899243-22-006419 8474
2022-02-15 4 FORM 4 SUBMISSION 0000899243-22-006417 7494
2022-02-15 4 FORM 4 SUBMISSION 0000899243-22-006413 7475
2022-02-15 4 FORM 4 SUBMISSION 0000899243-22-006412 7458
2022-02-14 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-22-000523 005-91966 22628776 34 277217
2022-02-11 SC 13G/A SC 13G/A 0001104659-22-020358 005-91966 22619931 34 78185
2022-02-11 SC 13G CHI ADVISORS LLC 0001085146-22-000830 005-91966 22619071 34 27929
2022-02-10 SC 13G SC 13G 0001104659-22-019462 005-91966 22614872 34 282872
2022-02-09 SC 13G SCHEDULE 13G 0001104659-22-016932 005-91966 22606932 34 13117
2022-01-13 4 FORM 4 SUBMISSION 0000899243-22-001926 7627
2022-01-10 3 OWNERSHIP DOCUMENT 0000921895-22-000115 23688
2021-12-29 8-K 8-K 5.02 0001193125-21-368422 001-39856 211526123 34 154799 1 1
2021-12-20 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-21-002879 005-91966 211505862 34 277281
2021-12-16 8-K 8-K 7.01,9.01 0001193125-21-358521 001-39856 211495973 34 8590930 1 1
2021-11-09 10-Q 10-Q 0001564590-21-055440 001-39856 211389842 34 11675452 1 1
2021-11-09 8-K 8-K 2.02,9.01 0001193125-21-323714 001-39856 211389814 34 255290 1 1
2021-11-08 SC 13G sc13g07422010_11082021.htm 0000921895-21-002540 005-91966 211388951 34 285278
2021-10-20 4 FORM 4 SUBMISSION 0000899243-21-040774 5752
2021-10-20 3 FORM 3 SUBMISSION 0000899243-21-040768 7786
2021-10-20 4 FORM 4 SUBMISSION 0000899243-21-040764 13580
2021-10-18 4 FORM 4 SUBMISSION 0000899243-21-040454 8897
2021-10-18 4 FORM 4 SUBMISSION 0000899243-21-040453 4944
2021-10-18 8-K 8-K 5.02,7.01,9.01 0001193125-21-300558 001-39856 211327338 34 272236 1 1
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039858 4943
2021-09-21 4 FORM 4 SUBMISSION 0000899243-21-036782 11513
2021-09-21 4 FORM 4 SUBMISSION 0000899243-21-036781 5449
2021-09-20 4 FORM 4 SUBMISSION 0001209191-21-056914 9730
2021-09-20 4 FORM 4 SUBMISSION 0001209191-21-056913 7719
2021-09-16 4 FORM 4 SUBMISSION 0001209191-21-056411 11900
2021-09-16 4 FORM 4 SUBMISSION 0001209191-21-056409 11614
2021-09-13 4 FORM 4 SUBMISSION 0001209191-21-055726 14072
2021-09-13 4 FORM 4 SUBMISSION 0001209191-21-055725 15512
2021-09-09 4 FORM 4 SUBMISSION 0000899243-21-035415 9914
2021-09-09 4 FORM 4 SUBMISSION 0000899243-21-035417 11494
2021-09-08 4 FORM 4 SUBMISSION 0001209191-21-055203 14074
2021-09-08 4 FORM 4 SUBMISSION 0001209191-21-055200 15516
2021-09-08 4 FORM 4 SUBMISSION 0000899243-21-035331 5455
2021-09-02 4 FORM 4 SUBMISSION 0001209191-21-054518 16241
2021-09-02 4 FORM 4 SUBMISSION 0001209191-21-054517 19368
2021-08-31 4 FORM 4 SUBMISSION 0001209191-21-054094 11618
2021-08-31 4 FORM 4 SUBMISSION 0001209191-21-054093 11902
2021-08-26 4/A FORM 4/A SUBMISSION 0000899243-21-034314 14032
2021-08-26 4/A FORM 4/A SUBMISSION 0000899243-21-034312 11789
2021-08-26 4/A FORM 4/A SUBMISSION 0000899243-21-034311 5710
2021-08-26 4 FORM 4 SUBMISSION 0000899243-21-034306 9914
2021-08-25 4 FORM 4 SUBMISSION 0001209191-21-053380 15988
2021-08-25 4 FORM 4 SUBMISSION 0001209191-21-053379 15669

Latest XBRL company facts

One latest value per concept from companyfacts (223 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 64.92M 2026-11-04 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
dei EntityPublicFloat Entity Public Float USD 442.20M 2025-06-30 2025 FY 10-K 2026-03-10 0001193125-26-099362
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.61M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183465
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.15M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183465
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.33M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183465
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.10M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183465
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 98.1 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183465
ffd NetFeeAmt NetFeeAmt USD 0 2026-04-28 S-3ASR 2026-04-28 0001193125-26-183596
ffd TtlFeeAmt TtlFeeAmt USD 27,620 2026-04-28 S-3ASR 2026-04-28 0001193125-26-183596
ffd TtlOfferingAmt TtlOfferingAmt USD 200.00M 2026-04-28 S-3ASR 2026-04-28 0001193125-26-183596
ffd TtlOffsetAmt TtlOffsetAmt USD 27,620 2026-04-28 S-3ASR 2026-04-28 0001193125-26-183596
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-28 S-3ASR 2026-04-28 0001193125-26-183596
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 2.40M 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 7.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 2.44M 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016258
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 38.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.44M 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 969,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -652,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.02B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 22.87M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 24.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 16.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap Assets Assets USD 322.56M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AssetsCurrent Assets, Current USD 298.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 392.02M 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 669,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 223.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 223.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap Cash Cash USD 2.90M 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 88.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 289.60M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 88.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -72,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 64.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 64.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -218.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -154.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ConvertibleDebt Convertible Debt USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028346
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 100,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 3.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.70M 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 174.55M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 11.41M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 765,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 85.76M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 9.56M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 2.28M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 173.78M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 695,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 70,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 211,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.3 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122795
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.27 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.3 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122795
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.152 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.022 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028346
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.063 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.021 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028346
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.003 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure -0.05 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 36.10M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap EscrowDepositsRelatedToPropertySales Escrow Deposits Related to Property Sales USD 5.00M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-040964
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 36.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028346
us-gaap IncomeLossAttributableToNoncontrollingInterest Income (Loss) Attributable to Noncontrolling Interest, before Tax USD -800,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -219.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 1.60M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 33.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -46.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 2.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 3.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 13.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 293,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028346
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 18,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -281,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 32,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 11.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 500,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024683
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.25M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 872,000 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 906,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 906,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 157,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 249,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap Liabilities Liabilities USD 41.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 322.56M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LiabilitiesCurrent Liabilities, Current USD 40.13M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap LongTermInvestments Long-term Investments USD 21.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 124.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -127.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -219.88M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183465
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336717
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 5.67M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 2.13M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028346
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingExpenses Operating Expenses USD 163.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -163.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingLeaseCost Operating Lease, Cost USD 147,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 900,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingLeaseLeaseIncomeLeasePayments Operating Lease, Lease Income, Lease Payments USD 300,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 859,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.118 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 312.60M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.75M 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024683
us-gaap OtherAssetsCurrent Other Assets, Current USD 3.90M 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 297,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -1.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 2.47M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap OtherIncome Other Income USD 10.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap OtherLongTermInvestments Other Long-term Investments USD 15.50M 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-060679
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -236,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 6.57M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021253
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 69.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -1.45M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 448.55M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001564590-21-055440
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 161,094 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 161,094 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 619,000 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8.58M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ProceedsFromContributionsFromParent Proceeds from Contributions from Parent USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 2.20M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024683
us-gaap ProceedsFromIncomeTaxRefundFederal ProceedsFromIncomeTaxRefundFederal USD 3.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ProceedsFromIncomeTaxRefundStateAndLocal ProceedsFromIncomeTaxRefundStateAndLocal USD 3.90M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028346
us-gaap ProceedsFromPaymentsToMinorityShareholders Proceeds from (Payments to) Noncontrolling Interests USD 1.15M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024683
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 193.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.59M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -152.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.39M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 210,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 126.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 6.45M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -740.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap RoyaltyExpense Royalty Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap SegmentExpenditureAdditionToLongLivedAssets SegmentExpenditureAdditionToLongLivedAssets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 24.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.698 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 7.50M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 9.45M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.15 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 10.27M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 13.81M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 15.13 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 9.62 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.52 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 9.18 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap SharePrice Share Price USD/shares 12.98 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024683
us-gaap ShortTermInvestments Short-term Investments USD 201.31M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 408.73M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 281.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 320,228 2021-01-01 2021-01-31 2021 FY 10-K 2022-03-17 0000950170-22-004002
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 3,336 2024-04-01 2024-06-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268066
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 373 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336717
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 501,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 56,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 218,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006839
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.06M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 380,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 8.37M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454417
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.59M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap SubleaseIncome Sublease Income USD 500,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions Subsidiary or Equity Method Investee, Cumulative Proceeds Received on All Transactions USD 277.90M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-14 0000950170-24-031143
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 42.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099362
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 52.16M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122795
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 44.43M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009937
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 52.16M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122795

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →